Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Surgical ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Eighth edition of the AJCC cancer staging manual: breast cancer.Ann Surg Oncol. 2018; 25: 1783-1785
- Estimation of the number of women living with metastatic breast cancer in the united states.Cancer Epidemiol Biomarkers Prev. 2017; 26: 809-815
- Breast Cancer Facts & Figures 2019-2020.
- Initial surgery and survival in stage IV Breast cancer in the united states, 1988-2011.JAMA Surg. 2016; 151: 424-431
- Role of operative management in stage IV breast cancer.Surg Clin North Am. 2018; 98: 859-868https://doi.org/10.1016/j.suc.2018.03.012
- Nephrectomy followed by interferon Alfa-2b compared with interferon Alfa-2b alone for metastatic renal-cell cancer.N Engl J Med. 2001; 345: 1655-1659
- Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.Lancet. 2001; 358: 966-970
- NCCN clinical practice guidelines in oncology: breast cancer, Version 1.2022.(Available at:)
- Breast cancer-specific survival by age: worse outcomes for the oldest patients.Cancer. 2018; 124: 2184-2191
- Stage-specific survival rate of breast cancer patients in northern thailand in accordance with two different staging systems.Asian Pac J Cancer Prev. 2019; 20: 2699-2706
- Does removal of the primary tumor in metastatic breast cancer improve survival?.J Womens Health (Larchmt). 2014; 23: 184-188
- New perspectives in clinical oncology from angiogenesis research.Eur J Cancer. 1996; 32: 2534-2539
- Experimental studies of factors influencing the development of hepatic metastases: XIII. Effect of hepatic trauma in parabiotic pairs.Cancer Res. 1963; 23: 896-900
- Surgical injury enhances the expression of genes that mediate breast cancer metastasis to the lung.Ann Surg. 2010; 252: 1037-1043
- Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601.Eur J Cancer. 2013; 49: 90-97
- Does aggressive local therapy improve survival in metastatic breast cancer? Surgery.. 2002; 132 ([discussion: 626-7]): 620-626
- Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis.J Clin Oncol. 2006; 24: 2743-2749
- Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988–2003 SEER data.Ann Surg Oncol. 2007; 14: 2187-2194
- Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.Ann Surg Oncol. 2006; 13: 776-782
- Primary Tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival.Ann Surg Oncol. 2013; 20: 1893-1899
- Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis.Ann Surg Oncol. 2007; 14: 3345-3351
- Association of surgery with improved survival in stage IV breast cancer patients.Ann Surg. 2008; 247: 732-738
- Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival.Breast Cancer Res Treat. 2009; 115: 7-12
- Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis.Eur J Surg Oncol (EJSO). 2009; 35: 1146-1151
- Primary tumor resection in metastatic breast cancer: a propensity-matched analysis, 1988-2011 SEER data base.Breast J. 2018; 24: 549-554
- Benefits of surgical treatment of stage IV breast cancer for patients with known hormone receptor and HER2 status.Ann Surg Oncol. 2021; 28: 2646-2658
- Surgery of the primary tumor does not improve survival in stage IV breast cancer.Breast Cancer Res Treat. 2011; 129: 459-465
- Matched pair analyses of stage IV breast cancer with or without resection of primary breast site.Ann Surg Oncol. 2008; 15: 3384-3395
- Abstract P2-18-09: TBCRC 013: a prospective analysis of the role of surgery in stage IV breast cancer.Cancer Res. 2013; 73 (18-09-P2-18-09): P2
- A prospective analysis of surgery and survival in stage IV breast cancer (TBCRC 013).J Clin Oncol. 2016; 34: 1006
- Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.Lancet Oncol. 2015; 16: 1380-1388
- Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: protocol MF07-01.Ann Surg Oncol. 2018; 25: 3141-3149
- Impact of breast surgery in primary metastasized breast cancer: outcomes of the prospective randomized phase III ABCSG-28 POSYTIVE trial.Ann Surg. 2019; 269: 1163-1169
- Early local therapy for the primary site in de novo stage IV breast cancer: results of a randomized clinical trial (EA2108).J Clin Oncol. 2022; 40: 978-987
- A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: a trial of the ECOG-ACRIN Research Group (E2108).J Clin Oncol. 2020; 38: LBA2
- A randomized controlled trial comparing primary tumor resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (JCOG1017 PRIM-BC).J Clin Oncol. 2017; 35: TPS588
- Early locoregional breast surgery and survival in de novo metastatic breast cancer in the multicenter national ESME cohort.Ann Surg. 2021; https://doi.org/10.1097/sla.0000000000004767
- Primary metastatic breast cancer in the era of targeted therapy – Prognostic impact and the role of breast tumour surgery.Eur J Cancer. 2017; 83: 116-124
- Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy.Cancer. 2015; 121: 4324-4332
- A Role for curative surgery in the treatment of selected patients with metastatic breast cancer.Oncologist. 2003; 8: 241-251
- Prognostic factors for resection of isolated pulmonary metastases in breast cancer patients: a systematic review and meta-analysis.J Thorac Dis. 2015; 7: 1441-1451
- NRG-BR002: a phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic breast cancer (NCT02364557).J Clin Oncol. 2019; 37: TPS1117
- Population-based statistics for women diagnosed with inflammatory breast cancer (United States).Cancer Causes & Control. 2004; 15: 321-328
- Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.Breast Cancer Res Treat. 2015; 152: 407-416
- Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer.Cancer. 2014; 120: 1319-1328
- Inflammatory breast cancer: patterns of failure and the case for aggressive locoregional management.Ann Surg Oncol. 2015; 22: 2483-2491
- Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation.Springerplus. 2014; 3: 166
Article info
Publication history
Published online: October 17, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
